MiMedx details how EY quit as auditor for troubled Atlanta biomedical company

MiMedx's shares (OTC: MDXG), which traded on Nasdaq as high as $17 at the begining of 2018, were delisted by Nasdaq in November and have now fallen to $1.15.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news